MILLENIA HOPE HIRES BALTIC INVESTMENTS
By Adnews Staff
Montreal-based biotech company Millenia Hope has retained corporate consultants Baltic Investments to raise its profile in Europe. Millenia Hope's flagship product is Malarex, an anti-malarial drug. "Millenia Hope is quickly maturing into a stable biotech player and we expect Baltic Investments to aid us in disseminating and sharing our corporate vision with our European investors," said Dominique Morisot, president and chief executive officer of Millenia Hope.
« Back Next »
Comments
blog comments powered by Disqus